Katherine Helen Schiavoni, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fees and Charges | 1 | 2016 | 194 | 0.550 |
Why?
|
| Physicians, Primary Care | 1 | 2016 | 573 | 0.380 |
Why?
|
| Pediatrics | 2 | 2021 | 3553 | 0.340 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 3959 | 0.210 |
Why?
|
| Family Planning Services | 1 | 2021 | 234 | 0.180 |
Why?
|
| Geobacter | 1 | 2012 | 4 | 0.120 |
Why?
|
| Cytochrome c Group | 1 | 2012 | 133 | 0.110 |
Why?
|
| Cardiolipins | 1 | 2011 | 83 | 0.110 |
Why?
|
| Cytochromes c | 1 | 2011 | 184 | 0.100 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2010 | 59 | 0.100 |
Why?
|
| Qualitative Research | 2 | 2016 | 2554 | 0.100 |
Why?
|
| Cross-Sectional Studies | 3 | 2022 | 23437 | 0.100 |
Why?
|
| Heme | 1 | 2012 | 291 | 0.100 |
Why?
|
| Reimbursement, Incentive | 1 | 2015 | 520 | 0.100 |
Why?
|
| Medicaid | 1 | 2022 | 2649 | 0.090 |
Why?
|
| Health Personnel | 1 | 2021 | 3045 | 0.080 |
Why?
|
| Prevalence | 1 | 2022 | 14912 | 0.070 |
Why?
|
| Quality Indicators, Health Care | 1 | 2015 | 1825 | 0.070 |
Why?
|
| Child | 2 | 2022 | 74468 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 1 | 2010 | 1413 | 0.060 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 4881 | 0.060 |
Why?
|
| Physician-Patient Relations | 1 | 2016 | 3318 | 0.060 |
Why?
|
| Pregnancy | 1 | 2021 | 27398 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2977 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 2973 | 0.050 |
Why?
|
| Adult | 2 | 2022 | 212279 | 0.040 |
Why?
|
| Risk Factors | 1 | 2022 | 70879 | 0.030 |
Why?
|
| Blue Cross Blue Shield Insurance Plans | 1 | 2015 | 94 | 0.030 |
Why?
|
| Young Adult | 1 | 2021 | 56228 | 0.030 |
Why?
|
| United States | 1 | 2022 | 67910 | 0.030 |
Why?
|
| Humans | 5 | 2022 | 715818 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2021 | 72473 | 0.030 |
Why?
|
| Adolescent | 1 | 2021 | 85157 | 0.030 |
Why?
|
| Protein Refolding | 1 | 2012 | 6 | 0.030 |
Why?
|
| Guanidine | 1 | 2012 | 33 | 0.030 |
Why?
|
| Fluorescence Polarization | 1 | 2011 | 133 | 0.030 |
Why?
|
| Female | 3 | 2021 | 377229 | 0.030 |
Why?
|
| Horses | 1 | 2011 | 294 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 2011 | 696 | 0.020 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2011 | 343 | 0.020 |
Why?
|
| Information Storage and Retrieval | 1 | 2015 | 835 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2011 | 508 | 0.020 |
Why?
|
| Reimbursement Mechanisms | 1 | 2015 | 658 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2010 | 633 | 0.020 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2010 | 337 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2012 | 2597 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2012 | 1821 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 2299 | 0.020 |
Why?
|
| Water | 1 | 2012 | 1321 | 0.020 |
Why?
|
| Ligands | 1 | 2012 | 3294 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 3964 | 0.020 |
Why?
|
| Kinetics | 1 | 2012 | 6654 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2011 | 4041 | 0.020 |
Why?
|
| Massachusetts | 1 | 2015 | 8743 | 0.010 |
Why?
|
| Neurodegenerative Diseases | 1 | 2010 | 951 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2011 | 5467 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2015 | 4282 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2015 | 3738 | 0.010 |
Why?
|
| Protein Binding | 1 | 2011 | 9558 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2010 | 3129 | 0.010 |
Why?
|
| Male | 1 | 2016 | 350352 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2010 | 19905 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 16735 | 0.010 |
Why?
|
| Animals | 2 | 2011 | 169404 | 0.010 |
Why?
|
| Mice | 1 | 2010 | 80373 | 0.000 |
Why?
|